{"id":3582,"date":"2023-06-15T17:37:33","date_gmt":"2023-06-15T15:37:33","guid":{"rendered":"http:\/\/www.internalmed-journal.in.ua\/?p=3582"},"modified":"2023-08-11T14:18:02","modified_gmt":"2023-08-11T12:18:02","slug":"%d0%ba%d0%be%d0%bc%d0%be%d1%80%d0%b1%d1%96%d0%b4%d0%bd%d0%b8%d0%b9-%d0%bf%d0%b0%d1%86%d1%96%d1%94%d0%bd%d1%82-%d0%bc%d1%96%d0%b6%d0%b4%d0%b8%d1%81%d1%86%d0%b8%d0%bf%d0%bb%d1%96%d0%bd%d0%b0%d1%80","status":"publish","type":"post","link":"http:\/\/www.internalmed-journal.in.ua\/en\/archives\/3582","title":{"rendered":"Comorbid patient: an interdisciplinary problem (literature review)"},"content":{"rendered":"

Prof<\/strong>. <\/strong>Kravchun<\/strong> N<\/strong>.<\/strong>O<\/strong>., <\/strong>assoc<\/strong>. <\/strong>prof<\/strong>. <\/strong>Dunaieva<\/strong> I<\/strong>.<\/strong>P<\/strong>., <\/strong>assoc<\/strong>. <\/strong>prof<\/strong>. <\/strong>Yakovenko<\/strong> O<\/strong>.<\/strong>L<\/strong>., <\/strong>prof<\/strong>. <\/strong>Kravchun<\/strong> P<\/strong>.<\/strong>P<\/strong>.<\/strong><\/p>\n

\u00a0<\/strong>Kharkiv National Medical University <\/strong><\/p>\n

The comorbidity of arterial hypertension (AH), type 2 diabetes mellitus (T2DM), obesity leads to the early development of atherosclerotic lesions of coronary and cerebral vessels, which, in turn, significantly accelerates the occurrence of coronary arterial disease (CHD), vascular disasters, namely, myocardial infarction (MI), stroke. Comorbidity fully refers to the concept of “metabolic syndrome”. By definition, metabolic syndrome (MS) is a complex of interrelated clinical, metabolic and hormonal disorders caused by the dysregulation of various genes, the influence of external environmental factors, associated with increased cardiovascular risk, and an increase in overall mortality. The article is intended to review modern scientific literature on metabolic syndrome and comorbid conditions associated with it.<\/p>\n

Key words:<\/strong> metabolic syndrome, arterial hypertension, comorbidity, type 2 diabetes.<\/p>\n

\u00a0<\/strong>https:\/\/doi.org\/10.15407\/internalmed2023.02.076<\/strong><\/a><\/p>\n

Download.PDF (ukr)<\/strong><\/a><\/p>\n

Cite:<\/strong><\/p>\n

    \n
  1. \u041a\u0440\u0430\u0432\u0447\u0443\u043d, \u041d.\u041e. \u041a\u043e\u043c\u043e\u0440\u0431\u0456\u0434\u043d\u0438\u0439 \u043f\u0430\u0446\u0456\u0454\u043d\u0442: \u043c\u0456\u0436\u0434\u0438\u0441\u0446\u0438\u043f\u043b\u0456\u043d\u0430\u0440\u043d\u0430 \u043f\u0440\u043e\u0431\u043b\u0435\u043c\u0430 (\u043e\u0433\u043b\u044f\u0434 \u043b\u0456\u0442\u0435\u0440\u0430\u0442\u0443\u0440\u0438) \/ \u041d.\u041e. \u041a\u0440\u0430\u0432\u0447\u0443\u043d, \u0406.\u041f. \u0414\u0443\u043d\u0430\u0454\u0432\u0430, \u041e.\u041b. \u042f\u043a\u043e\u0432\u0435\u043d\u043a\u043e, \u041f.\u041f. \u041a\u0440\u0430\u0432\u0447\u0443\u043d \/\/ \u0421\u0445\u0456\u0434\u043d\u043e\u0454\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b \u0432\u043d\u0443\u0442\u0440\u0456\u0448\u043d\u044c\u043e\u0457 \u0442\u0430 \u0441\u0456\u043c\u0435\u0439\u043d\u043e\u0457 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0438. – 2023. – \u2116 2. – \u0421. 76-79. http:\/\/doi.org\/10.15407\/internalmed2023.02.076<\/li>\n
  2. Kravchun NO, Dunaieva IP, Yakovenko OL, Kravchun PP. [Comorbid patient: an interdisciplinary problem (literature review)]. Shidnoevr. z. vnutr. simejnoi med. 2023;2:76-79. Ukrainian. http:\/\/doi.org\/10.15407\/internalmed2023.02.076<\/li>\n<\/ol>\n

    References:<\/strong><\/p>\n

      \n
    1. Karki R, Kodamullil A, Hofmann-Apitius M. Comorbidity Analysis between Alzheimer\u2019s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs. Journal of Alzheimer’s Disease. 2017;60(2):721-731. http:\/\/dx.doi.org\/10.3233\/jad-170440<\/li>\n
    2. Edward Anyasodor A, Uba Nwose E, Stuart Richards R, Taderera Bwititi P, Awharentomah Digban K, Itietie Mudiaga L, Aganbi E, Ojodeme O. Co-morbidity of Diabetes Mellitus and Orodental Diseases in Nigeria. Current Diabetes Reviews. 2017;13(3):289-299. http:\/\/dx.doi.org\/10.2174\/1573399812666160413114146<\/li>\n
    3. Mohilnytska LA. Kontsentratsiia vaskuloendotelialnoho faktoru rostu v syrovattsi krovi khvorykh z arterialnoiu hipertenziieiu, shcho suprovodzhuietsia tsukrovym diabetom 2 typu, ozhyrinniam. Visnyk problem biolohii i medytsyny 2017;4(141):158\u2013163. doi: 10.29254\/2077\u20134214\u20132017\u20134\u20133\u2013 141\u2013158\u2013163. Ukrainian<\/li>\n
    4. Liashuk RP, Liashuk PM. Metabolichnyi syndrom yak mizhdystsyplinarna problema (ohliad literatury). Mizhnarodnyi endokrynolohichnyi zhurnal 2017. tom 13 (7). doi: 10.22141\/2224-0721.13.7.2017.115748; 43-46. Ukrainian<\/li>\n
    5. McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clinics in Dermatology. 2018;36(1):14-20. http:\/\/dx.doi.org\/10.1016\/j.clindermatol.2017.09.004<\/li>\n
    6. Saklayen M. The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports. 2018;20(2):. http:\/\/dx.doi.org\/10.1007\/s11906-018-0812-z<\/li>\n
    7. Reaven G. Role of Insulin Resistance in Human Disease. Diabetes. 1988;37(12):1595-1607. http:\/\/dx.doi.org\/10.2337\/diab.37.12.1595<\/li>\n
    8. Pankiv VI. Insulinorezystentnist yak kliuchovyi patofiziolohichnyi mekhanizm rozvytku metabolichnoho syndrome. Prakt.anhiolohiia. 2012;5\u20136(54\u201355):24\u201328. Ukrainian<\/li>\n
    9. Kopchak OO. Metabolichnyi syndrom ta yoho vklad u rozvytok sudynnykh kohnityvnykh porushen. Ukr.med.chasopys. 2014;2:178\u2013182. Ukrainian<\/li>\n
    10. Koren D, Taveras E. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome. Metabolism. 2018;84:67-75. http:\/\/dx.doi.org\/10.1016\/j.metabol.2018.04.001<\/li>\n
    11. Santilli F, D\u2019Ardes D, Guagnano M, Davi G. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach. Current Medicinal Chemistry. 2017;24(24):. http:\/\/dx.doi.org\/10.2174\/0929867324666170710121145<\/li>\n
    12. Psarova VH, Kyrychenko NM, Kochuieva MM. Vplyv insulinorezystentnosti na sudynne remoduliuvannia pry komorbidnosti arterialnoi hypertenzii i ozhyrinnia. Simeina medytsyna. 2019;5-6(85-86):74-6. Ukrainian<\/li>\n
    13. Tune J, Goodwill A, Sassoon D, Mather K. Cardiovascular consequences of metabolic syndrome. Translational Research. 2017;183:57-70. http:\/\/dx.doi.org\/10.1016\/j.trsl.2017.01.001<\/li>\n
    14. Shah S, Hill A. Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy: Republication. Current Opinion in HIV and AIDS. 2021;16(2):106-114. http:\/\/dx.doi.org\/10.1097\/coh.0000000000000671<\/li>\n
    15. Lehrke M, Marx N. Diabetes Mellitus and Heart Failure. The American Journal of Cardiology. 2017;120(1):S37-S47. http:\/\/dx.doi.org\/10.1016\/j.amjcard.2017.05.014<\/li>\n
    16. Lastra G, Syed S, Kurukulasuriya L, Manrique C, Sowers J. Type 2 Diabetes Mellitus and Hypertension. Endocrinology and Metabolism Clinics of North America. 2014;43(1):103-122. http:\/\/dx.doi.org\/10.1016\/j.ecl.2013.09.005<\/li>\n
    17. Markle-Reid M, Ploeg J, Fraser K, Fisher K, Bartholomew A, Griffith L, Miklavcic J, Gafni A, Thabane L, Upshur R. Community Program Improves Quality of Life and Self-Management in Older Adults with Diabetes Mellitus and Comorbidity. Journal of the American Geriatrics Society. 2017;66(2):263-273. http:\/\/dx.doi.org\/10.1111\/jgs.15173<\/li>\n
    18. Rajpathak S. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016 Jul;32(7):1243-52. doi: 10.1185\/03007995.2016.1168291.<\/li>\n
    19. Kolomoiets MIu, Vyshniak \u041e\u041e. Komorbidnist i polimorbidnist u terapevtychnii praktytsi. Ukr. med.chasopys. 2012;5(91):140\u2013143. Ukrainian<\/li>\n
    20. Einarson T, Acs A, Ludwig C, Panton U. Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review. Value in Health. 2018;21(7):881-890. http:\/\/dx.doi.org\/10.1016\/j.jval.2017.12.019<\/li>\n
    21. Moon J, Kwak S, Jang H. Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus. The Korean Journal of Internal Medicine. 2017;32(1):26-41. http:\/\/dx.doi.org\/10.3904\/kjim.2016.203<\/li>\n
    22. Iskra DA. Komorbidnost’ sakharnogo diabeta 2-go tipa i boli v spine [Comorbidity of type 2 diabetes mellitus and low back pain]. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8):126-130. doi: 10.17116\/jnevro2018118081126. PMID: 30251990.<\/li>\n
    23. Corser W. Increasing comorbidity with diabetes in the community: Diabetes research challenges. Diabetes Research and Clinical Practice. 2013;100(2):173-180. http:\/\/dx.doi.org\/10.1016\/j.diabres.2012.11.011<\/li>\n
    24. Chow J, Nie J, Shawn Tracy C, Wang L, Upshur R. Comorbidity in Very Old Adults with Type 2 Diabetes Mellitus. Journal of the American Geriatrics Society. 2013;61(6):1028-1029. http:\/\/dx.doi.org\/10.1111\/jgs.12288<\/li>\n
    25. Tabatabaei-Malazy O, Nikfar S, Larijani B, Abdollahi M. Drugs for the treatment of pediatric type 2 diabetes mellitus and related co-morbidities. Expert Opinion on Pharmacotherapy. 2016;17(18):2449-2460. http:\/\/dx.doi.org\/10.1080\/14656566.2016.1258057<\/li>\n
    26. Huang C, Hsieh H, Tu H, Jiang H, Wang P, Lin C. Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics. European Psychiatry. 2018;54:102-108. http:\/\/dx.doi.org\/10.1016\/j.eurpsy.2018.08.002<\/li>\n
    27. Maghana M. Obesity and Arthritis. Maghana M. Menopause International. 2008;14(4):149\u2013154.<\/li>\n
    28. Richette P. What is New in Osteoarthritis Front. Richette P, Funk P, Brentano T. Eur. Masculoskel. Rev. 2010;5(22):8\u201310.<\/li>\n
    29. Katz J, Agrawal S, Velasquez M. Getting to the heart of the matter: osteoarthritis takes its place as part of the metabolic syndrome. Current Opinion in Rheumatology. 2010;22(5):512-519. http:\/\/dx.doi.org\/10.1097\/bor.0b013e32833bfb4b<\/li>\n
    30. de Groot M, Doyle T, Averyt J, Risaliti C, Shubroo J. Depressive Symptoms and Type 2 Diabetes Mellitus in Rural Appalachia: an 18-Month Follow-Up Study. The International Journal of Psychiatry in Medicine. 2014;48(4):263-277. http:\/\/dx.doi.org\/10.2190\/pm.48.4.c<\/li>\n
    31. Nasonova TI. Patohenetychni aspekty preventyvnoi korektsii kohnytyvnykh porushen pry metabolichnomu syndromi. Mizhnarodnyi endokrynolohichnyi zhurnal. 2016;1(73):61\u201369. Ukrainian<\/li>\n
    32. Huang C, Hsieh H, Tu H, Jiang H, Wang P, Lin C. Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics. European Psychiatry. 2018;54:102-108. http:\/\/dx.doi.org\/10.1016\/j.eurpsy.2018.08.002<\/li>\n
    33. Mendenhall E, Norris S, Shidhaye R, Prabhakaran D. Depression and type 2 diabetes in low- and middle-income countries: A systematic review. Diabetes Research and Clinical Practice. 2014;103(2):276-285. http:\/\/dx.doi.org\/10.1016\/j.diabres.2014.01.001<\/li>\n
    34. Punthakee Z, Goldenberg R, Katz P. Diabetes Canada Clinical Practice Guidelines Expert Committee. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes. 2018;:S10-S15. doi: 10.1016\/j.jcjd.2017.10.003. PMID: 29650080<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

      Prof. Kravchun N.O., assoc. prof. Dunaieva I.P., assoc. prof. Yakovenko O.L., prof. Kravchun P.P. \u00a0Kharkiv National Medical University The comorbidity of arterial hypertension (AH), type 2 diabetes mellitus (T2DM), obesity leads to the early development of atherosclerotic lesions of coronary and cerebral vessels, which, in turn, significantly accelerates the occurrence of coronary arterial disease (CHD),…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,13,9,62,24,108,105,103,102,104],"tags":[],"translation":{"provider":"WPGlobus","version":"2.12.2","language":"en","enabled_languages":["uk","en","ru"],"languages":{"uk":{"title":true,"content":true,"excerpt":false},"en":{"title":true,"content":true,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false}}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/3582"}],"collection":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/comments?post=3582"}],"version-history":[{"count":6,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/3582\/revisions"}],"predecessor-version":[{"id":3745,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/3582\/revisions\/3745"}],"wp:attachment":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/media?parent=3582"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/categories?post=3582"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/tags?post=3582"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}